- Home
- PMVP vs VGI Comparison
PMVP vs VGI Comparison
Compare PMVP & VGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.19
Company Overview
Basic Information| Metric | PMVP | VGI |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.0M | 88.4M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PMVP | VGI |
|---|---|---|
| Price | $1.19 | $7.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 217.0K | 46.0K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.66% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.81 | $6.68 |
| 52 Week High | $1.84 | $7.99 |
Technical Indicators
Market Signals| Indicator | PMVP | VGI |
|---|---|---|
| Relative Strength Index (RSI) | 42.61 | 60.79 |
| Support Level | $1.20 | $7.82 |
| Resistance Level | $1.26 | $7.94 |
| Average True Range (ATR) | 0.05 | 0.07 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 47.16 | 59.86 |
Price Performance
Historical Comparison PMVP
VGI
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About VGI Virtus Global Multi-Sector Income Fund of Beneficial Interest
Virtus Global Multi-Sector Inc is a United States based fund. Its investment objective is to maximize current income while preserving capital. The Fund seeks to achieve its investment objective by applying extensive credit research to capitalize on opportunities across undervalued areas of the international bond markets.